ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF

WIPO Patent Application WO/2022/203399

A1

The present invention relates to an antagonist of an adenosine A2A receptor, a pharmaceutical composition containing same for preventing or treating adenosine A2A receptor-related disease (for example cancer), and a method for treating and preventing disease by using same. The compound of chemical formula 1 according to the present invention exhibits excellent antagonistic activity for adenosine A2A receptors and thus, can effectively prevent or treat adenosine A2A receptor-related diseases (for example, cancer).

WO/2022/235717	BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE
JP5823398	New amides and thioamides as pesticides
WO/2020/073031	FUSED BICYCLIC HETEROCYCLES AS THEREAPEUTIC AGENTS

LEE HYO SEON (KR)
KIM SIU (KR)
CHO DAE HYUN (KR)

PCT/KR2022/004084

September 29, 2022

March 23, 2022

Click for automatic bibliography generation  

STANDIGM INC (KR)

C07D405/14; A61K31/506; A61K45/06; A61P35/00; C07D403/04; C07D403/14; C07D413/14; C07D417/14

WO2020079457A1

2020-04-23

KR20150138383A	2015-12-09
US20110009405A1	2011-01-13
US20130231519A1	2013-09-05

GIRAUD FRANCIS, ALVES GEORGES, DEBITON ERIC, NAUTON LIONEL, THÉRY VINCENT, DURIEU EMILIE, FERANDIN YOAN, LOZACH OLIVIER, MEIJER LA: "Synthesis, Protein Kinase Inhibitory Potencies, and in Vitro Antiproliferative Activities of Meridianin Derivatives", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 54, no. 13, 14 July 2011 (2011-07-14), US , pages 4474 - 4489, XP055971031, ISSN: 0022-2623, DOI: 10.1021/jm200464w

RYU, Jong Woo et al. (KR)

View/Download PDF      PDF Help

Previous Patent: MOBILE ROBOT DRIVING WHEEL DEFORMING DEVICE AND MOBILE ROBOT COMPRISING SAME

Next Patent: METHOD AND DEVICE FOR EXECUTION OF DEEP NEURAL NETWORK IN IOT EDGE NETWORK